Abstract:Breast cancer is the most common form of cancer and the second cancer-causing death in females. Although remission rates are high if detected early, survival rates drop substantially when breast cancer becomes metastatic. Metastatic relapse can occur months to years after the initial diagnosis and treatment of the primary tumor. This relapse is mediated by awakening of dormant disseminated cancer cells (dDCCs). Studies have demonstrated that the relationship between the microenvironment and dDCCs is critical for maintaining both dormancy and for facilitating awakening to promote metastasis development. Prior studies have shown increased inflammation in the microenvironment can facilitate DCC awakening and outgrowth. Viral respiratory infections are also associated with massive inflammation and immune cell influx, typically in acute form. Respiratory infections affect millions of people worldwide, as is particularly evident in the ongoing SARS-CoV2 pandemic and variably severe annual influenza seasons. How the inflammatory response to viral respiratory infections impacts breast cancer metastasis remains unclear. Using FVB MMTV-erbB2/neu/HER2 mice as a model of breast dormancy in the lungs and influenza virus, we show that following influenza infection there is a significant increase in the number of disseminated cancer cells in the lungs of influenza infected mice with more than a 1000-fold expansion of carcinoma cells over a couple of weeks. Interestingly most of this expansion of DCCs takes place within 10 days following influenza infection. Strikingly, by 15 days post-infection, the lesions that expanded from solitary HER2+ DCCs almost homogeneously return to a quiescent state. Furthermore, we show interleukin-6 is required for the early phase of dormant cancer cells reawakening and proliferation and that CD4+ T cells are required for the maintenance of the expanded cancer cells post-infection at the late phase. Depletion of CD4 T cells (but not CD8 cells) during infection with influenza virus leads to the elimination of the expanded DCC population in the lung. Finally, single-cell RNA-seq analyses of DCC and microenvironmental cells in the lungs before and after infection reveals insight into underlying mechanisms for virus-induced awakening and reentry into dormancy. scRNA-seq analyses reveal that expanding DCC post-influenza infection reprogram CD4 and CD8 T-cells to a more immune suppressed state. These results support a model whereby pulmonary viral infections can increase the risk of metastatic relapse in the lungs for patients with a prior history of breast cancer. Thus, the immune response evolved to combat respiratory infections can be coopted and reprogrammed by dormant cancer cells to enable their expansion, thus increasing the odds of further metastatic cancer evolution. Ongoing work is currently being done to investigate this process in mouse models of SARS-CoV2 infection, as well as to examine clinical databases for epidemiological associations between respiratory viral infections and metastatic disease in the lung. Citation Format: Bryan J. Johnson, Shi Biao Chia, Vadym Zaberezhnyy, Varsha Sreekanth, Meher Boorgula, Michael Papanicolaou, James Costello, Andrew Goodspeed, Julio A. Aguirre-Ghiso, Mercedes Rincon, James V. DeGregori. Influenza-induced inflammatory response reactivates and promotes dormant breast cancer cell outgrowth in lungs [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr B021.

Redirecting host preexisting influenza A virus immunity for cancer immunotherapy

Influenza Training of Granulopoiesis Promotes Long-Term Anti-Leukemia Activity

Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer

An engineered influenza virus to deliver antigens for lung cancer vaccination

A recombinant influenza virus with a CTLA4‐specific scFv inhibits tumor growth in a mouse model

Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.

Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

Immunobiochemical Reconstruction of Influenza Lung Infection-Melanoma Skin Cancer Interactions

Abstract 6664: In situ vaccination with hyper-interferon sensitive influenza induces adaptive immune response and sensitizes murine non-small cell lung cancer to PD-1 blockade

A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity

Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine non-small cell lung cancer

Abstract B021: Influenza-induced inflammatory response reactivates and promotes dormant breast cancer cell outgrowth in lungs

Targeted Delivery of Tumor Antigens to Activated Dendritic Cells Via CD11c Molecules Induces Potent Antitumor Immunity in Mice

Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza

Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells

Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs

Abstract 5345: Development and validation of humanized HLA mouse model platforms for preclinical evaluation of novel peptide vaccines

In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts

Intracellular Salmonella delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice